newsfilter
← Latest News
GlobeNewswire·

Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer treatment, today announced the appointment of Steve Sab